Royal Bank Of Canada Amneal Pharmaceuticals, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 37,839 shares of AMRX stock, worth $301,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,839
Previous 33,401
13.29%
Holding current value
$301,576
Previous $212,000
48.11%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AMRX
# of Institutions
183Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$174 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$117 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$98.3 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$89.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$85.5 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.21B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...